Sunday Star-Times

Magic mushrooms on the ballot

-

‘‘I’m very fortunate that I was able to find this therapy . . . It’s not an overestima­te by any means to say that it saved my life.’’ Chad Kuske, Psilocybin therapy patient and former US Navy SEAL

War veterans with PTSD, terminally ill patients and others suffering from anxiety are backing a ballot measure that would legalise the controlled, therapeuti­c use in Oregon of psilocybin mushrooms, which they say has helped them immeasurab­ly.

‘‘After chemo failed, I went to a pretty dark place,’’ said Mara McGraw, a Portland woman who has terminal cancer. ‘‘I was feeling hopeless about treatment and about the future.’’

Then she tried the psychedeli­c mushroom, more commonly known as ‘‘ magic mushrooms’’, with a trained facilitato­r standing by.

‘‘It was a very safe and nurturing experience for me. I immediatel­y felt a release from the fear.’’

On the national level, a clinical trial of psilocybin is under way to test its potential antidepres­sant properties, the US Government’s National Library of Medicine says.

Backers of Oregon’s Measure 109 say the state, which was the first in the US to decriminal­ise cannabis, should lead the way in legalising the therapeuti­c, regulated use of psilocybin.

A second ballot question, Measure 110, would decriminal­ise possession of small amounts of heroin, cocaine, LSD, oxycodone and some other drugs. Its backers say drug addiction is a health issue and should not cause people to be jailed and saddled with criminal records.

If Oregon voters approve Measure 110, the state would be the first to decriminal­ise those drugs.

The psilocybin initiative, however, is about overcoming depression, supporters say.

‘‘An estimated one in every five adults in Oregon is coping with a mental health condition,’’ 20 doctors and other health care workers wrote in a pamphlet sent to voters. ‘‘We support Measure 109 because it provides a new treatment for many that might break through where others fall short.’’

It would require the Oregon Health Authority to allow licensed, regulated production and possession of psilocybin exclusivel­y for administra­tion by licensed facilitato­rs to patients. There would be a two-year developmen­t period for the programme.

The only argument in opposition in the pamphlet came from the Oregon Psychiatri­c Physicians Associatio­n and the American Psychiatri­c Associatio­n. ‘‘ We believe that science does not yet indicate that psilocybin is a safe medical treatment for mental health conditions,’’ the groups said.

But several military veterans believe psilocybin therapy is a lifesaver, especially when the suicide rate among US veterans is so high. About 20 veterans die by suicide each day in the US, about 1.5 times higher than those who have not served in the military.

Chad Kuske said he developed post-traumatic stress disorder after serving as a US Navy SEAL for 18 years with 12 combat deployment­s. ‘‘I was really suffering from stress, anxiety, depression. I was angry all the time.’’

Then a former member of his team visited Kuske in Portland on his way to a psilocybin therapy session. Through his friend, Kuske also signed up for one.

‘‘ I’m very fortunate that I was able to find this therapy, administer­ed by people who care and who really had my best interests in mind and do it in the proper setting,’’ Kuske said.

‘‘There’s no way that the words that I can use could really explain it. It’s not an overestima­te by any means to say that it saved my life, because the path that I was taking would have eventually just led me to continued suffering, jail or or death. I don’t know that I would have ever really broken the cycle of returning to alcohol and drugs without this.’’

Chris Stauffer is a physician scientist at the Portland Veterans Affairs Medical Centre who conducts clinical trials of psychedeli­cassisted therapy. He’s also an assistant professor of psychiatry at the Oregon Health and Science University.

He says that during a psilocybin session lasting several hours, subjects often have eyeshades and headphones on, to help them look inward.

For music, Stauffer tends to borrow from a ‘‘ Psilocybin Research: Johns Hopkins’’ playlist on Spotify, featuring classical composers such as Vivaldi and Brahms, and calming New Age and flute music. The playlist ends on an upbeat note, with What A Wonderful World, sung by Louis Armstrong.

‘‘We try to make space for the entire range of emotional experience, knowing that whatever comes up is coming up for healing,’’ Stauffer said. ‘‘Even if it’s something that seems scary or overwhelmi­ng, we encourage them to move into it and try to move through it and not avoid it.’’

The other drug- related ballot measure, the Drug Addiction Treatment and Recovery Act, recently received a US$500,000 (NZ$757,000) donation from Facebook CEO Mark Zuckerberg and his wife, Dr Priscilla Chan.

‘‘Its significan­ce is monumental. If the measure passes, Oregon will shift to a health-based approach to drugs and addiction,’’ the Chan Zuckerberg Initiative website says.

‘‘Instead of arrests and criminal conviction­s, people possessing small amounts of drugs will get civil infraction­s that can be waived if they get assessed for drug treatment needs.’’

All cannabis tax revenue above US$11.25 million quarterly would fund addiction recovery centres, along with legislativ­e appropriat­ions and any savings from reductions in arrests and incarcerat­ion resulting from the measure.

Among those supporting it are the Oregon Nurses Associatio­n and the Oregon chapter of the American College of Physicians.

About two dozen district attorneys in Oregon are urging a no vote, however. ‘‘This measure recklessly decriminal­ises possession of the most dangerous types of drugs, including methamphet­amine, cocaine, heroin and ecstasy,’’ they wrote in the voters’ pamphlet. ‘‘Decriminal­isation will lead to an increase in acceptabil­ity of dangerous drugs.’’

 ?? AP ?? A vendor bags psilocybin mushrooms at a pop-up cannabis market in Los Angeles. Voters in Oregon are set to decide on a measure that would legalise the therapeuti­c, regulated use of psilocybin. A second ballot question proposes decriminal­ising possession of small amounts of other drugs, including heroin, cocaine and LSD.
AP A vendor bags psilocybin mushrooms at a pop-up cannabis market in Los Angeles. Voters in Oregon are set to decide on a measure that would legalise the therapeuti­c, regulated use of psilocybin. A second ballot question proposes decriminal­ising possession of small amounts of other drugs, including heroin, cocaine and LSD.

Newspapers in English

Newspapers from New Zealand